Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study

<b>Introduction:</b> Interleukin 6 receptor inhibition by tocilizumab (TCZ) has been effectively used worldwide for the treatment of multisystem inflammatory syndrome (MIS) associated with COVID-19. In this single centre study, we compared the outcome of COVID-19 pneumonia in TCZ-treated vs. untreat...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Zsófia Kardos, Miklós Szabó, Zsuzsanna Baráth, Ágnes Miksi, Csaba Oláh, Ádám Kozma, József A. Gergely, Eszter Csánky, Zoltán Szekanecz
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2023-01-01
Serie:	Biomedicines
Soggetti:	COVID-19 IL-6 receptor tocilizumab pneumonia efficacy
Accesso online:	https://www.mdpi.com/2227-9059/11/2/349
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!